Role of glutathione in augmenting the anticancer activity of pyrroloquinoline quinone (PQQ)

Redox Report

Volumn 15, Issue 4, 2010, Pages 146-154

  Shankar, Bhavani S ^a   Pandey, Ruchi ^a   Amin, Prayag ^a   Misra, Hari S ^a   Sainis, Krishna B ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

apoptosis; glutathione; necrosis; PQQ; pro oxidant; pyrroloquinoline quinone

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; LIPOCORTIN 5; PROPIDIUM IODIDE; PYRROLOQUINOLINEQUINONE; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE; CELL LINE, TUMOR; GLUTATHIONE; HUMANS; IN SITU NICK-END LABELING; MICE; NIH 3T3 CELLS; PQQ COFACTOR; REACTIVE OXYGEN SPECIES; U937 CELLS;

BACTERIA (MICROORGANISMS);

EID: 77955065733     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/174329210X12650506623762     Document Type: Article

References (36)

1. Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 1999; 26: 107-116.
2. Boots AW, Kubben N, Haenen GR, Bast A. Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation. Biochem Biophys Res Commun 2003; 308: 560-565.
3. Boots AW, Li H, Schins RP et al. The quercetin paradox. Toxicol Appl Pharmacol 2007; 222: 89-96.
4. Chung SH, Chung SM, Lee JY, Kim SR, Park KS, Chung JH. The biological significance of non-enzymatic reaction of menadione with plasma thiols: enhancement of menadione-induced cytotoxicity to platelets by the presence of blood plasma. FEBS Lett 1999; 449: 235-240.
5. Monks TJ, Jones DC. The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. Curr Drug Metab 2002; 3: 425-438.
6. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in toxicology. Chem Res Toxicol 2000; 13: 135-160.
7. Salisbury SA, Forrest HS, Cruse WB, Kennard O. A novel coenzyme from bacterial primary alcohol dehydrogenases. Nature 1979; 280: 843-844.
8. Fluckiger R, Paz M, Mah J, Bishop A, Gallop PM. Characterization of the glycine-dependent redox-cycling activity in animal fluids and tissues using specific inhibitors and activators: evidence for presence of PQQ. Biochem Biophys Res Commun 1993; 196: 61-68.
9. Aizenman E, Hartnett KA, Zhong C, Gallop PM, Rosenberg PA. Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory site. JNeurosci 1992; 12: 2362-2369.
10. Zhang Y, Rosenberg PA. The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur J Neurosci 2002; 16: 1015-1024.
11. Miyauchi K, Urakami T, Abeta H, Shi H, Noguchi N, Niki E. Action of pyrroloquinolinequinol as an antioxidant against lipid peroxidation in solution. Antioxid Redox Signal 1999; 1: 547-554.
12. He K, Nukada H, Urakami T, Murphy MP. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem Pharmacol 2003; 65: 67-74.
13. Hirakawa A, Shimizu K, Fukumitsu H, Furukawa S. Pyrroloquinoline quinone attenuates iNOS gene expression in the injured spinal cord. Biochem Biophys Res Commun 2009; 378: 308-312.
14. Zhu BQ, Simonis U, Cecchini G et al. Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther 2006; 11: 119-128.
15. Sato K, Toriyama M. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma. J Dermatol Sci 2009; 53: 140-145.
16. Kosano H, Setogawa T, Kobayashi K, Nishigori H. Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by alpha-melanocyte stimulating hormone in murine B16 melanoma cells. Life Sci 1995; 56: 1707-1713.
17. Adachi O, Okamoto K, Shinagawa E, Matsushita K, Ameyama M. Adduct formation of pyrroloquinoline quinone and amino acid. Biofactors 1988; 1: 251-254.
18. Shankar B, Kumar SS, Sainis KB. Generation of reactive oxygen species and radiation response in lymphocytes and tumor cells. Radiat Res 2003; 160: 478-487.
19. Myhre O, Andersen JM, Aarnes H, Fonnum F. Evaluation of the probes 2′,7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem Pharmacol 2003; 65: 1575-1582.
20. Kosower EM, Kosower NS. Bromobimane probes for thiols. Methods Enzymol 1995; 251: 133-148.
21. Rice GC, Bump EA, Shrieve DC, Lee W, Kovacs M. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res 1986; 46: 6105-6110.
22. Shankar B, Premachandran S, Bharambe SD, Sundaresan P, Sainis KB. Modification of immune response by low dose ionizing radiation: role of apoptosis. Immunol Lett 1999; 68: 237-245.
23. Ghibelli L, Coppola S, Fanelli C et al. Glutathione depletion causes cytochrome c release even in the absence of cell commitment to apoptosis. FASEB J1999; 13: 2031-2036.
24. Kumazawa T, Hiwasa T, Takiguchi M, Suzuki O, Sato K. Activation of Ras signaling pathways by pyrroloquinoline quinone in NIH3T3 mouse fibroblasts. Int J Mol Med 2007; 19: 765-770.
25. Tibodeau J, Benson L, Isham C, Owen W, Bible K. The Anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase. Antioxid Redox Signal 2009; 11: 1097-1106.
26. Madan E, Prasad S, Roy P, George J, Shukla Y. Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells. Biochem Biophys Res Commun 2008; 377: 1232-1237.
27. Liu Z, Huang SL, Li MM, Huang ZS, Lee KS, Gu LQ. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity. Chem Biol Interact 2009; 177: 48-57.
28. Chiou TJ, Chu ST, Tzeng WF. Protection of cells from menadione- induced apoptosis by inhibition of lipid peroxidation. Toxicology 2003; 191: 77-88.
29. O'Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 1991; 80: 1-41.
30. Verrax J, Delvaux M, Beghein N, Taper H, Gallez B, Buc Calderon P. Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study. Free Radic Res 2005; 39: 649-657.
31. Piga R, Saito Y, Yoshida Y, Niki E. Cytotoxic effects of various stressors on PC12 cells: involvement of oxidative stress and effect of antioxidants. Neurotoxicology 2007; 28: 67-75.
32. Thornton DE, Jones KH, Jiang Z, Zhang H, Liu G, Cornwell DG. Antioxidant and cytotoxic tocopheryl quinones in normal and cancer cells. Free Radic Biol Med 1995; 18: 963-976.
33. Wang D, Wei Y, Schmoll D, Maclean KN, Pagliassotti MJ. Endoplasmic reticulum stress increases glucose-6-phosphatase and glucose cycling in liver cells. Endocrinology 2006; 147: 350-358. (Pubitemid 43004288)
34. Han YH, Kim SZ, Kim SH, Park WH. Apoptosis in pyrogallol- treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. Lung Cancer 2008; 59: 301-314.
35. Naoi M, Yi H, Maruyama W et al. Glutathione redox status in mitochondria and cytoplasm differentially and sequentially activates apoptosis cascade in dopamine-melanin treated SH-SY5Y cells. Neurosci Lett 2009; 465: 118-122.
36. Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG, Nussler AK. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 2000; 89: 1440-1447.